Insmed, Inc. (INSM)
175.97
+5.70
(+3.35%)
USD |
NASDAQ |
Jan 09, 16:00
175.93
-0.04
(-0.02%)
After-Hours: 20:00
Insmed Research and Development Expense (Annual): 598.37M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.126B |
| Biogen, Inc. | 1.755B |
| Pfizer Inc. | 10.74B |
| Merck & Co., Inc. | 15.79B |
| CorMedix, Inc. | 3.942M |